Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 2
2022 1
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Acquired erythropoietic uroporphyria secondary to myeloid malignancy: A case report and literature review.
Serra-García L, Morgado-Carrasco D, Pérez-Valencia AI, Castaño-Díez S, Alamon-Reig F, Badenas C, To-Figueras J, Aguilera P. Serra-García L, et al. Among authors: perez valencia ai. Photodermatol Photoimmunol Photomed. 2022 Jan;38(1):86-91. doi: 10.1111/phpp.12720. Epub 2021 Aug 3. Photodermatol Photoimmunol Photomed. 2022. PMID: 34319628 Review. No abstract available.
Venetoclax with hypomethylating agents might lead to eradication of measurable residual disease (MRD) persisting after intensive chemotherapy in acute myeloid leukemia (AML) patients with mutated NPM1 and rearranged CBF.
Jiménez-Vicente C, Martínez-Roca A, Pomares H, Castaño-Diez S, Guijarro F, López-Guerra M, Bataller A, Esteban D, Cortés-Bullich A, Pérez-Valencia AI, Guardia-Torrelles A, Zugasti I, Rovira M, Fernández-Avilés F, Colomer D, Arnan M, Díaz-Beyá M, Esteve J. Jiménez-Vicente C, et al. Among authors: perez valencia ai. Leuk Res. 2023 Dec;135:107403. doi: 10.1016/j.leukres.2023.107403. Epub 2023 Sep 30. Leuk Res. 2023. PMID: 37837718 No abstract available.
New Cases and Mutations in SEC23B Gene Causing Congenital Dyserythropoietic Anemia Type II.
Musri MM, Venturi V, Ferrer-Cortès X, Romero-Cortadellas L, Hernández G, Leoz P, Ricard Andrés MP, Morado M, Fernández Valle MDC, Beneitez Pastor D, Ortuño Cabrero A, Moreno Gamiz M, Senent Peris L, Perez-Valencia AI, Pérez-Montero S, Tornador C, Sánchez M. Musri MM, et al. Among authors: perez valencia ai. Int J Mol Sci. 2023 Jun 9;24(12):9935. doi: 10.3390/ijms24129935. Int J Mol Sci. 2023. PMID: 37373084 Free PMC article.
Infrequent Presentations of Chronic NPM1-Mutated Myeloid Neoplasms: Clinicopathological Features of Eight Cases from a Single Institution and Review of the Literature.
Castaño-Díez S, Guijarro F, López-Guerra M, Pérez-Valencia AI, Gómez-Núñez M, Colomer D, Díaz-Beyá M, Esteve J, Rozman M. Castaño-Díez S, et al. Among authors: perez valencia ai. Cancers (Basel). 2024 Feb 7;16(4):705. doi: 10.3390/cancers16040705. Cancers (Basel). 2024. PMID: 38398096 Free PMC article. Review.
Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant.
Pérez-Valencia AI, Cascos E, Carbonell-Ordeig S, Charry P, Gómez-Hernando M, Rodríguez-Lobato LG, Suárez-Lledó M, Martínez-Cibrian N, Antelo MG, Solano MT, Arcarons J, Nomdedeu M, Cid J, Lozano M, Díaz-Ricart M, Rosiñol L, Esteve J, Urbano-Ispizua Á, Carreras E, Martínez C, Fernández-Avilés F, Rovira M, Salas MQ. Pérez-Valencia AI, et al. Blood Adv. 2023 May 23;7(10):2018-2031. doi: 10.1182/bloodadvances.2022008792. Blood Adv. 2023. PMID: 36453637 Free PMC article.
A novel ETV6::FGFR1 fusion gene in a myeloid/lymphoid neoplasm with FGFR1 rearrangement sensitive to specific FGFR1-2-3 inhibition.
Jiménez-Vicente C, Garrote M, López-Guerra M, Villamón E, Guijarro F, Perez-Valencia AI, Martinez-Roca A, Balaguer O, Álvarez-Larrán A, Hernández-Boluda JC, Rovira M, Colomer D, Diaz-Beyá M, Rozman M, Esteve J. Jiménez-Vicente C, et al. Among authors: perez valencia ai. Leuk Lymphoma. 2024 Mar;65(3):394-398. doi: 10.1080/10428194.2023.2295788. Epub 2023 Dec 20. Leuk Lymphoma. 2024. PMID: 38117930 No abstract available.
Successful management of three patients with autoimmune thrombotic thrombocytopenic purpura with paradigm-changing therapy: Caplacizumab, steroids, plasma exchange, rituximab, and intravenous immunoglobulins (CASPERI).
Cid J, Pérez-Valencia AI, Torrente MÁ, Ávarez-Larrán A, Díaz-Ricart M, Esteve J, Lozano M. Cid J, et al. Among authors: perez valencia ai. Transfus Apher Sci. 2021 Feb;60(1):103011. doi: 10.1016/j.transci.2020.103011. Epub 2020 Nov 7. Transfus Apher Sci. 2021. PMID: 33221124
A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphoma.
Mozas P, Casanueva-Eliceiry S, Rivero A, Serna Á, Simó M, Rodríguez S, Rivas-Delgado A, Nadeu F, Correa JG, Piñeyroa JA, Pérez-Valencia AI, Guinetti-Ortiz K, Gómez-Hernando M, Giné E, Delgado J, Villamor N, Campo E, Magnano L, Abrisqueta P, Setoain X, López-Guillermo A. Mozas P, et al. Among authors: perez valencia ai. Hematol Oncol. 2024 Jan;42(1):e3235. doi: 10.1002/hon.3235. Epub 2023 Nov 9. Hematol Oncol. 2024. PMID: 37942762